World Acceptance Stock (NASDAQ:WRLD), Trade Ideas

World Acceptance

World Acceptance Corp operates a small-loan consumer finance business. The company offers short-term small installment loans, medium-term larger installment loans, related credit insurance and ancillary products and services to individuals. It also offers income tax return preparation services to its loan customers and other individuals.

News

Penny Stocks

Small Cap

Intraday Update

Markets

Movers

Trading Ideas

ACON

AEHL

AGTI

AKLI

ATCH

BENF

BFLY

BREA

CLDX

CTCX

DHAI

DOGZ

FRPT

MicroCloud Hologram Inc. - Ordinary Shares

HOLO

IBRX

ITRI

KRYS

LUNR

MARA

MIST

NBSE

NEPT

NUWE

OCGN

PSNY

ROMA

SELX

SGRY

SKYT

TBIO

TEVA

THMO

TRNR

VERO

WRLD

ZJYL

ZVSA

Shares of  Freshpet, Inc. (NASDAQ: FRPT) gained 15.5% to $106.29 after the company reported better-than-expected fourth-quarter financial results.

Why Freshpet Shares Are Trading Higher By Around 15%? Here Are Other Stocks Moving In Monday&#39;s Mid-Day Session

MGNX

MRNA

NYXH

ORLA

PODD

SMMT

TMDX

U.S. stocks were slightly higher, with the Nasdaq Composite gaining around 10 points on Monday.

Shares of  Surgery Partners, Inc. (NASDAQ: SGRY) fell sharply during Monday’s session following weak quarterly sales.

Surgery Partners Posts Weak Sales, Joins Kosmos Energy, Moderna And Other Big Stocks Moving Lower On Monday

ABSI

ADAG

AGAE

AGFY

ALLY

ASTS

AXDX

AZTR

BCDA

BFRG

CELH

CHGG

CISS

CRGE

DTSS

ESPR

EWTX

GOOG

GOOGL

IRBT

KAMN

MESA

MESO

Morgan Stanley Capital Protected Notes for S&P 500 Index

NAMS

NKTX

ORGS

PCSA

PRTG

RNAZ

SAVE

SHPH

SILK

SMCI

SOAR

VMAR

Shares of TransCode Therapeutics, Inc. (NASDAQ: RNAZ) fell sharply during Friday’s session.

TransCode Therapeutics priced a 5,942,623 share common stock offering at $1.22 per share.

TransCode Therapeutics shares dipped 24.3% to $0.8248 on Friday.

Why TransCode Therapeutics Shares Are Trading Lower By Over 24%? Here Are Other Stocks Moving In Friday&#39;s Mid-Day Session

World Acceptance Corporation - Common Stock

World Acceptance Corp

Shares of Freshpet, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/frpt#NASDAQ">FRPT</a>) gained 15.5% to $106.29 after the company reported better-than-expected fourth-quarter financial results.
Freshpet posted quarterly earnings of 31 cents per share, beating market estimates of 5 cents per share. The company&rsquo;s quarterly sales came in at $215.42 million versus expectations of $204.36 million.
Freshpet shares gained 15.5% to $106.29 on Monday.
Here are some other stocks moving in today&#39;s mid-day session.
<h3>Gainers</h3>
<ul>
<li>Akili, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/akli#NASDAQ">AKLI</a>) shares jumped 126% to $0.5009 after the company reported positive results from Shionogi&#39;s Phase 3 clinical trial of localized version of Akili&#39;s EndeavorRx&reg; for Pediatric ADHD patients in Japan.</li>
<li>ZyVersa Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/zvsa#NASDAQ">ZVSA</a>) climbed 126% to $1.81 after surging over 30% on Friday.</li>
<li>MicroCloud Hologram Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/holo#NASDAQ">HOLO</a>) gained 107% to $13.71 after tumbling 40% on Friday.</li>
<li>Neptune Wellness Solutions Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nept#NASDAQ">NEPT</a>) rose 54.6% to $0.49.</li>
<li>Interactive Strength Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/trnr#NASDAQ">TRNR</a>) surged 32.2% to $0.8701 after the company announced it has entered into an exclusive worldwide distribution agreement with WOODWAY to sell and distribute CLMBR.</li>
<li>Agiliti, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/agti#NASDAQ">AGTI</a>) gained 29.4% to $9.89 after the company announced it will be taken private by THL Partners.</li>
<li>Krystal Biotech, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/krys#NASDAQ">KRYS</a>) surged 28.8% to $143.34 after the company reported better-than-expected financial results.</li>
<li>R1 RCM Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rcm#NYSE">RCM</a>) surged 26.7% to $14.06 after the company received an acquisition offer for the company valued at $13.75 per share.</li>
<li>Butterfly Network, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bfly#NASDAQ">BFLY</a>) gained 26.3% to $1.2880.</li>
<li>Altimmune, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/alt#NASDAQ">ALT</a>) surged 22.1% to $11.24.</li>
<li>Milestone Pharmaceuticals Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mist#NASDAQ">MIST</a>) gained 21.3% to $2.10 after the company announced plans to resubmit the New Drug Application (NDA) for etripamil to the U.S. Food and Drug Administration (FDA) for paroxysmal supraventricular tachycardia (PSVT).</li>
<li>Ocugen, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ocgn#NASDAQ">OCGN</a>) climbed 18.9% to $0.9451.</li>
<li>ImmunityBio, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ibrx#NASDAQ">IBRX</a>) gained 18% to $ 4.1250.</li>
<li>Li Auto Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/li#NASDAQ">LI</a>) rose 16.2% to $40.44 after the company reported fourth-quarter financial results above estimates and issued first-quarter guidance.</li>
<li>Nuwellis, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nuwe#NASDAQ">NUWE</a>) shares rose 16.1% to $0.7101.</li>
<li>SkyWater Technology, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/skyt#NASDAQ">SKYT</a>) gained 15.4% to $10.98.</li>
<li>ImmunityBio, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ibrx#NASDAQ">IBRX</a>) gained 14.3% to $3.9999 after dipping 33% on Friday.</li>
<li>Celldex Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cldx#NASDAQ">CLDX</a>) surged 13.9% to $43.00 following strong quarterly sales.</li>
<li>Polestar Automotive Holding UK PLC (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/psny#NASDAQ">PSNY</a>) gained 13.4% to $1.4850.</li>
<li>Itron, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/itri#NASDAQ">ITRI</a>) rose 12.3% to $84.11 after the company reported fourth-quarter financial results and issued first-quarter guidance above estimates.</li>
<li>HashiCorp, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hcp#NASDAQ">HCP</a>) gained 11.8% to $24.77 after Morgan Stanley upgraded the stock from Equal-Weight to Overweight and raised its price target from $23 to $30.</li>
<li>Marathon Digital Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mara#NASDAQ">MARA</a>) jumped 11.2% to $26.67.</li>
<li>NeuBase Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nbse#NASDAQ">NBSE</a>) shares surged 10.5% to $0.83. Neubase Therapeutics, on Feb. 22, said board determined for company to dissolve, liquidate and distribute to stockholders its available assets.</li>
<li>Carmell Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ctcx#NASDAQ">CTCX</a>) rose 9.9% to $2.47. Carmell announced product development has been completed for Gold Limited Edition Exclusive launch in March 2024.</li>
<li>Domino&#39;s Pizza, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/dpz#NYSE">DPZ</a>) gained 8.2% to $469.01 after the company&rsquo;s fourth quarter 2023 earnings surpassed Wall Street expectations, raised its quarterly dividend, and announced an additional share buyback plan.</li>
<li>NIO Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nio#NYSE">NIO</a>) rose 6.5% to $5.75. The company on Monday announced that it entered into a technology license agreement with Forseven Limited.</li>
<li>Teva Pharmaceutical Industries Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/teva#NYSE">TEVA</a>) shares gained 4.3% to $13.44 after the company announced FDA approval of its arthritis treatment.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>Aclarion, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/acon#NASDAQ">ACON</a>) shares fell 62.5% to $0.34 after the company priced its public offering of 5.175 million units. Each unit includes one share of common stock (or a pre-funded warrant), and two common warrants.</li>
<li>Venus Concept Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vero#NASDAQ">VERO</a>) dipped 28.8% to $0.93 after the company announced a $1.2 million registered direct offering at $1.465 per share.</li>
<li>DIH Holding US, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dhai#NASDAQ">DHAI</a>) fell 28.3% to $0.79.</li>
<li>ThermoGenesis Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/thmo#NASDAQ">THMO</a>) dipped 27.5% to $0.7601.</li>
<li>Intuitive Machines, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lunr#NASDAQ">LUNR</a>) fell 25.1% to $7.18 after the company said its lunar lander may have tipped over upon landing on the moon.</li>
<li>Semilux International Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/selx#NASDAQ">SELX</a>) declined 24.4% to $0.8615.</li>
<li>Brera Holdings PLC (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/brea#NASDAQ">BREA</a>) fell 21.8% to $0.8601.</li>
<li>Antelope Enterprise Holdings Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aehl#NASDAQ">AEHL</a>) dipped 21.8% to $1.50. Antelope Enterprise announced closing of $1.3 million registered direct offering and private placement.</li>
<li>NGM Biopharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ngm#NASDAQ">NGM</a>) fell 19.4% to $1.5399. NGM Bio has entered into a definitive agreement and plan of merger with certain affiliates of the Column Group, LP.</li>
<li>Telesis Bio, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tbio#NASDAQ">TBIO</a>) shares fell 17.8% to $0.6401. Telesis Bio shares jumped 72% on Friday after the company was granted EUR Patent #3503915 for &quot;Genetically Engineered Vibrio Natriegens (Host Organism For Cloning And Manipulating DNA).&quot;</li>
<li>Beneficient (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/benf#NASDAQ">BENF</a>) fell 17% to $0.1640. On Feb. 13, Beneficient posted a third-quarter loss of $1.98 per share.</li>
<li>Dogness (International) Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dogz#NASDAQ">DOGZ</a>) fell 17% to $6.14.</li>
<li>AtlasClear Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/atch#NYSE">ATCH</a>) shares fell 11.2% to $2.3450 after jumping over 131% on Friday.</li>
<li>Jin Medical International Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/zjyl#NASDAQ">ZJYL</a>) declined 11.2% to $6.30.</li>
<li>Roma Green Finance Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/roma#NASDAQ">ROMA</a>) fell 9.9% to $1.4599 after tumbling 11% on Friday.</li>
<li>Surgery Partners, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sgry#NASDAQ">SGRY</a>) dipped 7.8% to $30.43 following weak quarterly sales.</li>
<li>World Acceptance Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wrld#NASDAQ">WRLD</a>) fell 7% to $120.71. World Acceptance recently reported better-than-expected third-quarter financial results.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/news/24/02/37283655/intuit-to-rally-around-14-here-are-10-top-analyst-forecasts-for-friday"> Intuit To Rally Around 14%? Here Are 10 Top Analyst Forecasts For Friday </a>

Why Freshpet Shares Are Trading Higher By Around 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session

U.S. stocks were slightly higher, with the Nasdaq Composite gaining around 10 points on Monday.
Shares of Surgery Partners, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sgry#NASDAQ">SGRY</a>) fell sharply during Monday&rsquo;s session following <a href="https://www.benzinga.com/quote/SGRY/earnings">weak quarterly sales</a>.
Surgery Partners posted adjusted earnings of 44 cents per share, versus market estimates of 38 cents per share. The company&rsquo;s quarterly sales came in at $735.40 million missing expectations of $741.40 million, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
Surgery Partners shares tumbled 7.8% to $30.43 on Monday.
Here are some other big stocks recording losses in today&rsquo;s session.
<ul>
<li>Intuitive Machines, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lunr#NASDAQ">LUNR</a>) dipped 25.1% to $7.18 after the company said its lunar lander may have tipped over upon landing on the moon.</li>
<li>Nyxoah S.A. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nyxh#NASDAQ">NYXH</a>) fell 11.3% to $15.29. Nyxoah is expected to release fourth quarter financial results on March 5, 2024.</li>
<li>Jin Medical International Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/zjyl#NASDAQ">ZJYL</a>) fell 11.2% to $6.30.</li>
<li>TransMedics Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tmdx#NASDAQ">TMDX</a>) dipped 8.6% to $75.99. TransMedics Group is expected to release financial results for the fourth quarter after market close on Feb. 26, 2024.</li>
<li>World Acceptance Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wrld#NASDAQ">WRLD</a>) declined 7% to $120.71. World Acceptance recently reported better-than-expected third-quarter financial results.</li>
<li>MacroGenics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mgnx#NASDAQ">MGNX</a>) fell 7% to $16.88.</li>
<li>Kosmos Energy Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/kos#NYSE">KOS</a>) dipped 7% to $5.55. Kosmos Energy reported a fourth-quarter fiscal 2023 revenue decline of 10% year-over-year to $507.81 million, beating the consensus of $477.73 million.</li>
<li>Orla Mining Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/orla#NASDAQ">ORLA</a>) fell 6.8% to $3.38.</li>
<li>Insulet Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/podd#NASDAQ">PODD</a>) fell 5.8% to $173.54 after Barclays maintained an Equal-Weight rating on the stock and lowered its price target from $214 to $213.</li>
<li>Summit Therapeutics Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/smmt#NASDAQ">SMMT</a>) declined 5.6% to $4.38.</li>
<li>Moderna, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mrna#NASDAQ">MRNA</a>) fell 4.3% to $92.36 after HSBC downgraded the stock from Hold to Reduce but raised its price target from $75 to $86.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/news/24/02/37310145/top-3-defensive-stocks-that-may-collapse-in-february"> Top 3 Defensive Stocks That May Collapse In February </a>

Shares of TransCode Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rnaz#NASDAQ">RNAZ</a>) fell sharply during Friday&rsquo;s session.
TransCode Therapeutics priced a 5,942,623 share common stock offering at $1.22 per share.
TransCode Therapeutics shares dipped 24.3% to $0.8248 on Friday.
Here are some other stocks moving in today&#39;s mid-day session.
<h3>Gainers</h3>
<ul>
<li>Charge Enterprises, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/crge#NASDAQ">CRGE</a>) shares surged 105.4% to $0.2510.</li>
<li>Kaman Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/kamn#NASDAQ">KAMN</a>) shares climbed 101.3% to $45.14 after the company announced it will be acquired by Arcline for $1.8 billion.</li>
<li>Mesa Air Group Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mesa#NASDAQ">MESA</a>) gained 70.4% to $1.09 as the company entered into new agreements with United Airlines for improved operating and financing terms.</li>
<li>Edgewise Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ewtx#NASDAQ">EWTX</a>) rose 37.3% to $13.30 after the company announced pricing of its $240 million underwritten offering of 21,818,182 shares at $11 per share.</li>
<li>Processa Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pcsa#NASDAQ">PCSA</a>) climbed 34.2% to $0.2725. Processa Pharmaceuticals announced plans to expand the development of next generation capecitabine (NGC-Cap) into advanced or metastatic breast cancer beginning with next Phase 2 trial in breast cancer.</li>
<li>Tricon Residential Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tcn#NYSE">TCN</a>) shares gained 28.2% to $11.06 Blackstone and Tricon Residential entered into an arrangement agreement under which Blackstone Real Estate Partners X together with Blackstone Real Estate Income Trust, Inc. will acquire all outstanding common shares of Tricon for $11.25 per share in cash.</li>
<li>Spirit Airlines, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/save#NYSE">SAVE</a>) jumped 24% to $7.06 after the company announced preliminary fourth-quarter and full year 2023 estimates, issued first-quarter 2024 guidance and said the merger agreement between the company and JetBlue &quot;remains in full force and effect.&quot;</li>
<li>Super Micro Computer, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/smci#NASDAQ">SMCI</a>) climbed 23.1% to $383.31 after the company announced updated financial guidance for the second-quarter, which surpassed its previous outlook.</li>
<li>Allied Gaming &amp; Entertainment Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/agae#NASDAQ">AGAE</a>) rose 20.6% to $1.1190.</li>
<li>Portage Biotech Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/prtg#NASDAQ">PRTG</a>) gained 19% to $1.14.</li>
<li>ProMIS Neurosciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pmn#NASDAQ">PMN</a>) gained 19% to $2.07.</li>
<li>Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/shph#NASDAQ">SHPH</a>) gained 16.4% to $0.5185.</li>
<li>Treasure Global Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tgl#NASDAQ">TGL</a>) shares rose 14.2% to $0.1176. Treasure Global and AIO Synergy recently entered into a strategic alliance aimed at reshaping the landscape of artificial intelligence.</li>
<li>Silk Road Medical, Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/silk#NASDAQ">SILK</a>) jumped 13.1% to $14.91 after Stifel upgraded the stock from Hold to Buy and raised its price target from $9 to $20.</li>
<li>Wayfair Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/w#NYSE">W</a>) jumped 11.6% to $56.81 after the company announced a workforce realignment plan, which includes a workforce reduction involving approximately 13% of its global workforce.</li>
<li>Bullfrog AI Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bfrg#NASDAQ">BFRG</a>) gained 10.6% to $4.30.</li>
<li>NewAmsterdam Pharma Company N.V. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nams#NASDAQ">NAMS</a>) rose 10.5% to $19.44.</li>
<li>World Acceptance Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wrld#NASDAQ">WRLD</a>) gained 10.2% to $134.00 following upbeat quarterly results.</li>
<li>Ally Financial Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ally#NYSE">ALLY</a>) gained 9.4% to $35.15. Synchrony Financial announced plans to acquire Ally Financial&#39;s point of sale financing business. Ally Financial also posted upbeat quarterly sales.</li>
<li>Cyngn Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cyn#NASDAQ">CYN</a>) surged 8.8% to $0.1468 after gaining over 5% on Thursday.</li>
<li>Mesoblast Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/meso#NASDAQ">MESO</a>) gained 8.1% to $1.86 after the FDA granted a Rare Pediatric Disease Designation to the company&rsquo;s Revascor&reg; for treating children with congenital heart disease.</li>
<li>WNS (Holdings) Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/wns#NYSE">WNS</a>) rose 4.4% to $65.71. Needham analyst Mayank Tandon maintained WNS with a Buy and raised the price target from $80 to $85.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>C3is Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ciss#NASDAQ">CISS</a>) shares fell 63.2% to $0.1384 as the company announced pricing of $7.0 million upsized underwritten public offering.</li>
<li>Azitra, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/aztr#NYSE">AZTR</a>) dipped 31.8% to $1.3976 after the company filed for a firm commitment public offering of 3 million shares of common stock.</li>
<li>iRobot Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/irbt#NASDAQ">IRBT</a>) fell 30% to $16.53 following a report suggesting the EU plans to block Amazon&#39;s acquisition of the company.</li>
<li>Accelerate Diagnostics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/axdx#NASDAQ">AXDX</a>) fell 27.1% to $1.17 after the company reported pricing of approximately $15 million public offering and private placement.</li>
<li>AST SpaceMobile, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/asts#NASDAQ">ASTS</a>) declined 24.3% to $3.15. AST SpaceMobile announced a $100 million offering of common stock. The company also announced a strategic investment from AT&amp;T Inc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/t#NYSE">T</a>),</li>
<li>Alphabet Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/goog#NASDAQ">GOOG</a>) (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/googl#NASDAQ">GOOGL</a>) and Vodafone.</li>
<li>Agrify Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/agfy#NASDAQ">AGFY</a>) dipped 21.9% to $1.0699. Agrify entered into a multi-million dollar sales agreement with Ocean Deep/Golden Lake Business Park.</li>
<li>Adagene Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/adag#NASDAQ">ADAG</a>) fell 21.6% to $2.64.</li>
<li>BioCardia, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bcda#NASDAQ">BCDA</a>) fell 20% to $0.46.</li>
<li>Volato Group, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/soar#NYSE">SOAR</a>) fell 17.2% to $2.1688.</li>
<li>Datasea Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dtss#NASDAQ">DTSS</a>) shares fell 16.4% to $0.1140. Datasea announced plans for a 1-for-15 reverse stock split to regain compliance with Nasdaq minimum bid requirement.</li>
<li>Orgenesis Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/orgs#NASDAQ">ORGS</a>) dipped 15.3% to $0.2711.</li>
<li>Wheels Up Experience Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/up#NYSE">UP</a>) fell 12.6% to $3.19.</li>
<li>Nkarta, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nktx#NASDAQ">NKTX</a>) fell 12.2% to $7.47.</li>
<li>Vision Marine Technologies Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vmar#NASDAQ">VMAR</a>) shares fell 11.5% to $0.7098. Vision Marine Technologies announced close of $3.0 million private placement of convertible preferred shares and warrants with Investissement Qu&eacute;bec.</li>
<li>Absci Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/absi#NASDAQ">ABSI</a>) dipped 11.3% to $3.2120.</li>
<li>Lithium Americas Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/lac#NYSE">LAC</a>) fell 10.4% to $4.3650.</li>
<li>Celsius Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/celh#NASDAQ">CELH</a>) fell 10% to $53.60 after B of A Securities downgraded the stock from Buy to Neutral and announced a $65 price target.</li>
<li>Hut 8 Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/hut#NYSE">HUT</a>) dipped 9.4% to $6.45.</li>
<li>Lifezone Metals Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/lzm#NYSE">LZM</a>) fell 9.3% to $6.37.</li>
<li>MorphoSys AG (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mor#NASDAQ">MOR</a>) fell 7.3% to $9.49 after falling 6% on Wednesday. Morgan Stanley analyst James Quigley, on Tuesday, downgraded MorphoSys from Overweight to Equal-Weight.</li>
<li>Hertz Global Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/htz#NASDAQ">HTZ</a>) declined 6.6% to $8.40 after Jefferies downgraded the stock from Buy to Hold and lowered its price target from $12 to $8.</li>
<li>Esperion Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/espr#NASDAQ">ESPR</a>) shares fell 6.1% to $2.0188. Esperion priced its $85.1 million public offering of 56.7 million common share at $1.50 per share.</li>
<li>Chegg, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/chgg#NYSE">CHGG</a>) shares fell 6.1% to $9.45. Goldman Sachs analyst Eric Sheridan downgraded Chegg from Neutral to Sell and lowered the price target from $10 to $8.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/01/36690939/jim-cramer-predicts-a-terrific-year-for-this-manufacturer-and-as-for-u-haul-im-fine-with"> Jim Cramer Predicts A &#39;Terrific Year&#39; For This Manufacturer, And As For U-Haul? &#39;I&#39;m Fine With It&#39;</a>

Why TransCode Therapeutics Shares Are Trading Lower By Over 24%? Here Are Other Stocks Moving In Friday's Mid-Day Session

WIIM

World Acceptance shares are trading higher after the company reported better-than-expected Q3 financial results.

U.S. stocks traded higher, with the Dow Jones index gaining around 50 points on Friday.
Shares of World Acceptance Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wrld#NASDAQ">WRLD</a>) rose sharply during Friday&rsquo;s session following <a href="https://www.benzinga.com/quote/WRLD/earnings">upbeat quarterly results.</a>
World Acceptance posted quarterly earnings of $2.84 per share, beating market estimates of $1.88 per share. The company&rsquo;s quarterly sales came in at $137.75 million versus expectations of $130.58 million.
World Acceptance shares jumped 10.2% to $134.00 on Friday.
Here are some other big stocks recording gains in today&rsquo;s session.
<ul>
<li>Kaman Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/kamn#NASDAQ">KAMN</a>) shares gained 101.3% to $45.14 after the company announced it will be acquired by Arcline for $1.8 billion.</li>
<li>Edgewise Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ewtx#NASDAQ">EWTX</a>) jumped 37.3% to $13.30 after the company announced pricing of its $240 million underwritten offering of 21,818,182 shares at $11 per share.</li>
<li>Tricon Residential Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tcn#NYSE">TCN</a>) shares rose 28.2% to $11.06 Blackstone and Tricon Residential entered into an arrangement agreement under which Blackstone Real Estate Partners X together with Blackstone Real Estate Income Trust, Inc. will acquire all outstanding common shares of Tricon for $11.25 per share in cash.</li>
<li>Spirit Airlines, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/save#NYSE">SAVE</a>) climbed 24% to $7.06 after the company announced preliminary fourth-quarter and full year 2023 estimates, issued first-quarter 2024 guidance and said the merger agreement between the company and JetBlue &quot;remains in full force and effect.&quot;</li>
<li>Super Micro Computer, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/smci#NASDAQ">SMCI</a>) gained 23.1% to $383.31 after the company announced updated financial guidance for the second-quarter, which surpassed its previous outlook.</li>
<li>Silk Road Medical, Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/silk#NASDAQ">SILK</a>) shares rose 13.1% to $14.91 after Stifel upgraded the stock from Hold to Buy and raised its price target from $9 to $20.</li>
<li>Wayfair Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/w#NYSE">W</a>) surged 11.6% to $56.81 after the company announced a workforce realignment plan, which includes a workforce reduction involving approximately 13% of its global workforce.</li>
<li>NewAmsterdam Pharma Company N.V. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nams#NASDAQ">NAMS</a>) gained 10.5% to $19.44.</li>
<li>Ally Financial Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ally#NYSE">ALLY</a>) surged 9.4% to $35.15. Synchrony Financial announced plans to acquire Ally Financial&#39;s point of sale financing business. Ally Financial also posted upbeat quarterly sales.</li>
<li>MacroGenics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mgnx#NASDAQ">MGNX</a>) rose 7.7% to $11.59.</li>
<li>Fiverr International Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/fvrr#NYSE">FVRR</a>) rose 6.9% to $26.41. Goldman Sachs analyst Eric Sheridan upgraded Fiverr Intl from Neutral to Buy.</li>
<li>Plug Power Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/plug#NASDAQ">PLUG</a>) gained 6.4% to $2.5750.</li>
<li>WNS (Holdings) Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/wns#NYSE">WNS</a>) gained 4.4% to $65.71. Needham analyst Mayank Tandon maintained WNS with a Buy and raised the price target from $80 to $85.</li>
<li>State Street Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/stt#NYSE">STT</a>) rose 4.3% to $77.51 after the company reported better-than-expected fourth-quarter financial results and announced a new authorization to repurchase up to $5 billion of common shares.</li>
<li>Texas Instruments Incorporated (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/txn#NASDAQ">TXN</a>) gained 3.8% to $173.18. UBS analyst Timothy Arcuri upgraded Texas Instruments from Neutral to Buy and raised the price target from $170 to $195.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/01/36690939/jim-cramer-predicts-a-terrific-year-for-this-manufacturer-and-as-for-u-haul-im-fine-with"> Jim Cramer Predicts A &#39;Terrific Year&#39; For This Manufacturer, And As For U-Haul? &#39;I&#39;m Fine With It&#39;</a>

FVRR

PLUG

World Acceptance Posts Upbeat Earnings, Joins Kaman, Spirit Airlines And Other Big Stocks Moving Higher On Friday

World Acceptance (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WRLD#NASDAQ">WRLD</a>) reported quarterly earnings of $2.84 per share which beat the analyst consensus estimate of $1.88 by 51.06 percent. This is a 186.87 percent increase over earnings of $0.99 per share from the same period last year. The company reported quarterly sales of $137.75 million which beat the analyst consensus estimate of $130.58 million by 5.49 percent. This is a 5.97 percent decrease over sales of $146.50 million the same period last year.

Earnings

World Acceptance Q3 EPS $2.84 Beats $1.88 Estimate, Sales $137.75M Beat $130.58M Estimate

<h3>Companies Reporting Before The Bell</h3>
&bull; Ally Financial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALLY#NYSE">ALLY</a>) is likely to report quarterly earnings at $0.45 per share on revenue of $2.00 billion.
&bull; State Street (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STT#NYSE">STT</a>) is estimated to report quarterly earnings at $1.83 per share on revenue of $2.95 billion.
&bull; Huntington Bancshares (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HBAN#NASDAQ">HBAN</a>) is projected to report quarterly earnings at $0.27 per share on revenue of $1.77 billion.
&bull; Travelers Companies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TRV#NYSE">TRV</a>) is projected to report quarterly earnings at $5.02 per share on revenue of $9.99 billion.
&bull; Schlumberger (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SLB#NYSE">SLB</a>) is estimated to report quarterly earnings at $0.84 per share on revenue of $8.96 billion.
&bull; Comerica (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMA#NYSE">CMA</a>) is likely to report quarterly earnings at $1.36 per share on revenue of $839.36 million.
&bull; World Acceptance (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WRLD#NASDAQ">WRLD</a>) is estimated to report quarterly earnings at $1.88 per share on revenue of $130.58 million.
&bull; Regions Finl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RF#NYSE">RF</a>) is expected to report quarterly earnings at $0.46 per share on revenue of $1.80 billion.
&bull; Fifth Third Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FITB#NASDAQ">FITB</a>) is expected to report quarterly earnings at $0.85 per share on revenue of $2.16 billion.
<h3>&nbsp;</h3>
This article was generated by Benzinga&#39;s automated content engine and reviewed by an editor.

FITB

HBAN

Earnings Scheduled For January 19, 2024

World Acceptance (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WRLD#NASDAQ">WRLD</a>) is set to give its latest quarterly earnings report on Friday, 2024-01-19. Here's what investors need to know before the announcement.
Analysts estimate that World Acceptance will report an earnings per share (EPS) of $1.88. 
World Acceptance bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Past Earnings Performance</h3>
Last quarter the company beat EPS by $0.94, which was followed by a 0.0% drop in the share price the next day.
Here's a look at World Acceptance's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
<th>Q3 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>1.77</td>
<td>1.13</td>
<td>1.60</td>
<td>0.55</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>2.71</td>
<td>1.62</td>
<td>1.97</td>
<td>-0.78</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-4.9%</td>
<td>10.32%</td>
<td>6.45%</td>
<td>-4.96%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2024/1705586462_0.png" alt="eps graph" />
<h3>Stock Performance</h3>
Shares of World Acceptance were trading at $126.65 as of January 15. Over the last 52-week period, shares are up 58.55%. Given that these returns are generally positive, long-term shareholders should be satisfied going into this earnings release. 
<a href="https://www.benzinga.com/quote/WRLD/earnings">To track all earnings releases for World Acceptance visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Outlook For World Acceptance

Buybacks

On Nov 9, 2023, World Acceptance Corp Approved A Share Repurchase Program Authorizing The Company To Repurchase Up To $20M Of Its Outstanding Common Stock Inclusive Of Any Amount That Remains Available For Repurchase Under Prior Repurchase Authorizations

Gainers
INVO Bioscience, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/invo#NASDAQ">INVO</a>) jumped 375% to $2.57 as the company agreed to acquire NAYA Biosciences in an all-stock transaction.
LumiraDx Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lmdx#NASDAQ">LMDX</a>) shares climbed 187.4% to $0.25 after the company reported a strategic collaboration with AstraZeneca and Everton in the Community to set up England&rsquo;s first community-based heart and lung screening hub.
Akumin Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aku#NASDAQ">AKU</a>) shares climbed 125% to $0.3279 after the company reached an agreement with Stonepeak to become a private company.
Textainer Group Holdings Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tgh#NYSE">TGH</a>) shares gained 44.5% to $49.33 after the company agreed to be acquired by Stonepeak for $7.4 billion.
Twin Ridge Capital Acquisition Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/trca#NYSE">TRCA</a>) climbed 17.7% to $8.11.
Bright Green Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bgxx#NASDAQ">BGXX</a>) rose 17.6% to $0.4156.
Navios Maritime Holdings Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nm#NYSE">NM</a>) gained 17.2% to $2.21. N Logistics Holdings announced plans to acquire all outstanding shares of common stock of Navios Maritime Holdings not already owned by NLHC for $2.28 per share.
Motus GI Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mots#NASDAQ">MOTS</a>) gained 16.2% to $0.5576.
TeraWulf Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wulf#NASDAQ">WULF</a>) rose 16% to $1.2775
FLJ Group Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/flj#NASDAQ">FLJ</a>) jumped 15.8% to $0.3323.
NOVONIX Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nvx#NASDAQ">NVX</a>) climbed 15.4% to $2.10
The Alkaline Water Company Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wter#NASDAQ">WTER</a>) shares rose 14.6% to $0.2290 after falling 14% on Friday.
Nexalin Technology, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nxl#NASDAQ">NXL</a>) surged 13.6% to $0.3580.
Farfetch Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ftch#NYSE">FTCH</a>) rose 13% to $1.7850.
EngageSmart, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/esmt#NYSE">ESMT</a>) gained 12.1% to $22.65 after the company announced it would be acquired by Vista Equity Partners for $23 per share.
Digital Brands Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dbgi#NASDAQ">DBGI</a>) rose 11.2% to $5.36.
Abacus Life, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/abl#NASDAQ">ABL</a>) climbed 8.4% to $6.81.
Riot Platforms, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/riot#NASDAQ">RIOT</a>) shares gained 7.6% to $9.55 following a spike in Bitcoin.
Hut 8 Mining Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hut#NASDAQ">HUT</a>) gained 7% to $1.9889 amid a rise in Bitcoin.
Losers
Revolution Medicines, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rvmd#NASDAQ">RVMD</a>) fell 43.2% to $15.85 after the company announced it presented clinical activity and safety data from its Phase 1/1b trial of RMC-6236.
Li-Cycle Holdings Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/licy#NYSE">LICY</a>) shares fell 42.4% to $1.3087 after the company announced plans to halt construction work on its Rochester Hub project, pending completion of a comprehensive review of the go-forward strategy for the project..
Apollomics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aplm#NASDAQ">APLM</a>) dipped 38% to $1.08 after the company announced the presentation of vebreltinib efficacy and safety data from the KUNPENG clinical trial at ESMO 2023.
XORTX Therapeutics Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/xrtx#NASDAQ">XRTX</a>) fell 36.6% to $0.4050 after jumping more than 100% on Friday.
Aclarion, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/acon#NASDAQ">ACON</a>) fell 36% to $0.3597. Aclarion signed a LOI with ATEC to advance commercialization of Nociscan.
Great Ajax Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ajx#NYSE">AJX</a>) declined 33% to $4.26 after the company and Ellington Financial announced the mutual termination of their merger agreement.
Spectaire Holdings Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/spec#NASDAQ">SPEC</a>) fell 27.5% to $3.60.
Troika Media Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/trka#NASDAQ">TRKA</a>) shares fell 27.3% to $0.8001 after reporting financial results for the quarter ended June 30, 2023.
WANG &amp; LEE GROUP, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wlgs#NASDAQ">WLGS</a>) fell 26.3% to $0.56 after gaining over 38% on Friday.
Bruush Oral Care Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/brsh#NASDAQ">BRSH</a>) declined 23.7% to $0.38.
Agrify Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/agfy#NASDAQ">AGFY</a>) fell 23% to $1.86.
MMTec, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mtc#NASDAQ">MTC</a>) fell 21.1% to $1.1350.
Ambrx Biopharma Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/amam#NASDAQ">AMAM</a>) declined 20.9% to $6.66. Ambrx announced ARX517, a PSMA-targeted ADC, demonstrates 52% PSA50 (&ge;50% Reduction) and a highly differentiated safety and PK profile in patients with mCRPC, who progressed on multiple FDA-approved treatments.
Ryvyl Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rvyl#NASDAQ">RVYL</a>) fell 20% to $2.31.
C4 Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cccc#NASDAQ">CCCC</a>) declined 18.2% to $1.53.
FaZe Holdings Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/faze#NASDAQ">FAZE</a>) shares fell 17.4% to $0.1643. GameSquare Holdings and FaZe Holdings recently entered into a definitive agreement pursuant to which GameSquare will acquire FaZe Clan in an arm&#39;s length all-stock transaction.
Erayak Power Solution Group Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/raya#NASDAQ">RAYA</a>) fell 16.4% to $0.7101.
Biocept, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bioc#NASDAQ">BIOC</a>) fell 16.3% to $0.4730.
Harpoon Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/harp#NASDAQ">HARP</a>) shares fell 15.8% to $5.80 after the company. Harpoon announced a private placement of PIPE equity of up to $150 million. The company disclosed announced updated data from a trial evaluating its cancer drug.
Falcon&#39;s Beyond Global, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/fbyd#NASDAQ">FBYD</a>) dipped 15.6% to $14.57.
FMC Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/fmc#NYSE">FMC</a>) fell 12.7% to $58.52 after the company updated its third-quarter and FY23 outlook.
VinFast Auto Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vfs#NASDAQ">VFS</a>) fell 12.3% to $4.72. The company recently entered into a standby equity agreement with YA LL PN for an aggregate subscription amount of up to $1 billion.
ContraFect Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cfrx#NASDAQ">CFRX</a>) shares fell 11.9% to $0.3172 in pre-market trading after declining 10% on Friday. The company recently reported FDA clearance of CF-370 IND application to proceed with Phase 1 clinical study.
Catalyst Biosciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cbio#NASDAQ">CBIO</a>) fell 11.7% to $0.4414 in pre-market trading after climbing around 25% on Friday.
Intelligent Bio Solutions Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/inbs#NASDAQ">INBS</a>) fell 10.5% to $0.2417 in pre-market trading after gaining 10% on Friday.
Golden Sun Education Group Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gsun#NASDAQ">GSUN</a>) shares fell 10.1% to $0.4691 after declining 5% on Friday.
Okta, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/okta#NASDAQ">OKTA</a>) declined 8.9% to $68.87 on continued downward momentum after a threat actor breached its support system and viewed certain customer files. Also, Keybanc maintained an Overweight rating on the stock but lowered its price target from $106 to $95.
World Acceptance Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wrld#NASDAQ">WRLD</a>) fell 8% to $102.50 after BMO Capital maintained an Underperform rating on the stock and lowered its price target from $58 to $56.
NewAmsterdam Pharma Company N.V. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nams#NASDAQ">NAMS</a>) declined 7.4% to $6.50. NewAmsterdam Pharma named Ian Somaiya as Chief Financial Officer.
Now Read This: <a href="https://www.benzinga.com/markets/cryptocurrency/23/10/35374121/bitcoin-tops-this-key-level-fantom-emerges-as-top-gainer"> Bitcoin Tops This Key Level; Fantom Emerges As Top Gainer</a>

AMAM

APLM

BGXX

BIOC

BRSH

CBIO

CCCC

CFRX

DBGI

ESMT

FAZE

FBYD

FTCH

GSUN

HARP

Intelligent Bio Solutions Inc. - Common Stock

INBS

INVO

LICY

LMDX

MOTS

Nuveen California Dividend Advantage Municipal Fund 2

OKTA

RAYA

RIOT

RVMD

RVYL

SPEC

TRCA

TRKA

WLGS

WTER

WULF

XRTX

Why EngageSmart Shares Are Trading Higher By Around 12%? Here Are Other Stocks Moving In Monday's Mid-Day Session

BMO Capital has decided to maintain its Underperform rating of World Acceptance (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WRLD#NASDAQ">WRLD</a>) and lower its price target from $58.00 to $56.00.
Shares of World Acceptance are trading up 0.0% over the last 24 hours, at $111.39 per share.
A move to $56.00 would account for a 49.73% decline from the current share price.
<h3>About World Acceptance</h3>
World Acceptance Corp operates a small-loan consumer finance business. The company offers short-term small installment loans, medium-term larger installment loans, related credit insurance and ancillary products and services to individuals. It also offers income tax return preparation services to its loan customers and other individuals.
<h3>About Analyst Ratings</h3>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along with analyst success scores in <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Ratings

BMO Capital Maintains Underperform Rating for World Acceptance: Here's What You Need To Know

U.S. stocks traded slightly higher, with the Nasdaq Composite gaining around 10 points on Monday. Here are some big stocks recording losses in today&rsquo;s session.
Li-Cycle Holdings Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/licy#NYSE">LICY</a>) shares dipped 41% to $1.34 after the company announced plans to halt construction work on its Rochester Hub project, pending completion of a comprehensive review of the go-forward strategy for the project.
Revolution Medicines, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rvmd#NASDAQ">RVMD</a>) fell 38% to $17.31 after the company announced it presented clinical activity and safety data from its Phase 1/1b trial of RMC-6236.
Ambrx Biopharma Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/amam#NASDAQ">AMAM</a>) declined 22% to $6.58. Ambrx announced ARX517, a PSMA-targeted ADC, demonstrates 52% PSA50 (&ge;50% Reduction) and a highly differentiated safety and PK profile in patients with mCRPC, who progressed on multiple FDA-approved treatments.
FMC Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/fmc#NYSE">FMC</a>) fell 13.7% to $57.76 after the company updated its third-quarter and FY23 outlook.
VinFast Auto Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vfs#NASDAQ">VFS</a>) fell 11.4% to $4.76. The company recently entered into a standby equity agreement with YA LL PN for an aggregate subscription amount of up to $1 billion.
NewAmsterdam Pharma Company N.V. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nams#NASDAQ">NAMS</a>) declined 11.4% to $6.25. NewAmsterdam Pharma named Ian Somaiya as Chief Financial Officer.
FingerMotion, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/fngr#NASDAQ">FNGR</a>) fell 8.8% to $5.76.
YPF Sociedad An&oacute;nima (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ypf#NYSE">YPF</a>) fell 8.5% to $11.24.
Okta, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/okta#NASDAQ">OKTA</a>) declined 7.6% to $69.85 on continued downward momentum after a threat actor breached its support system and viewed certain customer files. Also, Keybanc maintained an Overweight rating on the stock but lowered its price target from $106 to $95.
World Acceptance Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wrld#NASDAQ">WRLD</a>) fell 6.8% to $103.71 after BMO Capital maintained an Underperform rating on the stock and lowered its price target from $58 to $56.
Perfect Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/perf#NYSE">PERF</a>) fell 6.8% to $2.61.
Formula Systems (1985) Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/forty#NASDAQ">FORTY</a>) declined 6% to $55.97.
Now Read This: <a href="https://www.benzinga.com/news/earnings/23/10/35372758/hexcel-likely-to-report-higher-q3-earnings-heres-a-look-at-recent-price-target-changes-by-the-most-"> Hexcel Likely To Report Higher Q3 Earnings; Here&#39;s A Look At Recent Price Target Changes By The Most Accurate Analysts</a>

FNGR

FORTY

PERF

FMC, Li-Cycle Holdings, Okta And Other Big Stocks Moving Lower On Monday

World Acceptance shares are trading lower after BMO Capital maintained an Underperform rating on the stock and lowered its price target from $58 to $56.

BMO Capital analyst James Fotheringham maintains World Acceptance (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WRLD#NASDAQ">WRLD</a>) with a Underperform and lowers the price target from $58 to $56.

Price Target

BMO Capital Maintains Underperform on World Acceptance, Lowers Price Target to $56

<h3>Companies Reporting Before The Bell</h3>
&bull; Berkshire Hills Bancorp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BHLB#NYSE">BHLB</a>) is expected to report quarterly earnings at $0.49 per share on revenue of $94.82 million.
&bull; World Acceptance (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WRLD#NASDAQ">WRLD</a>) is likely to report quarterly earnings at $1.77 per share on revenue of $135.86 million.
&bull; American Express (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AXP#NYSE">AXP</a>) is projected to report quarterly earnings at $2.94 per share on revenue of $15.36 billion.
&bull; Interpublic Gr of Cos (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IPG#NYSE">IPG</a>) is projected to report quarterly earnings at $0.73 per share on revenue of $2.38 billion.
&bull; First BanCorp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FBP#NYSE">FBP</a>) is expected to report quarterly earnings at $0.38 per share on revenue of $204.81 million.
&bull; Comerica (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMA#NYSE">CMA</a>) is likely to report quarterly earnings at $1.69 per share on revenue of $878.71 million.
&bull; Autoliv (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALV#NYSE">ALV</a>) is projected to report quarterly earnings at $1.84 per share on revenue of $2.64 billion.
&bull; Euronet Worldwide (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EEFT#NASDAQ">EEFT</a>) is estimated to report quarterly earnings at $2.70 per share on revenue of $983.96 million.
&bull; Sify Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SIFY#NASDAQ">SIFY</a>) is estimated to report earnings for its second quarter.
&bull; SLB (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SLB#NYSE">SLB</a>) is projected to report quarterly earnings at $0.77 per share on revenue of $8.33 billion.
&bull; OFG Bancorp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OFG#NYSE">OFG</a>) is likely to report quarterly earnings at $0.94 per share on revenue of $156.56 million.
&bull; Huntington Bancshares (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HBAN#NASDAQ">HBAN</a>) is expected to report quarterly earnings at $0.32 per share on revenue of $1.82 billion.
&bull; Sensient Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SXT#NYSE">SXT</a>) is estimated to report quarterly earnings at $0.75 per share on revenue of $371.80 million.
&bull; Regions Finl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RF#NYSE">RF</a>) is projected to report quarterly earnings at $0.58 per share on revenue of $1.89 billion.
<h3>&nbsp;</h3>
This article was generated by Benzinga&#39;s automated content engine and reviewed by an editor.

BHLB

EEFT

SIFY

Earnings Scheduled For October 20, 2023

World Acceptance (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WRLD#NASDAQ">WRLD</a>) reported quarterly earnings of $2.71 per share versus losses of $(0.11) per share from the same period last year. The company reported quarterly sales of $136.88 million which beat the analyst consensus estimate of $135.86 million by 0.75 percent. This is a 9&nbsp;percent decrease over sales of $151.2&nbsp;million the same period last year.

World Acceptance Q2 EPS $2.71 Vs. $(0.11) last Year, Sales $136.88M Beat $135.86M Estimate

World Acceptance (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WRLD#NASDAQ">WRLD</a>) is set to give its latest quarterly earnings report on Friday, 2023-10-20. Here's what investors need to know before the announcement.
Analysts estimate that World Acceptance will report an earnings per share (EPS) of $1.71. 
World Acceptance bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Historical Earnings Performance</h3>
Last quarter the company beat EPS by $0.49, which was followed by a 0.0% drop in the share price the next day.
Here's a look at World Acceptance's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
<th>Q3 2023</th>
<th>Q2 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>1.13</td>
<td>1.60</td>
<td>0.55</td>
<td>0.17</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>1.62</td>
<td>1.97</td>
<td>-0.78</td>
<td>-0.20</td>
</tr>
<tr>
<td>Price Change %</td>
<td>10.32%</td>
<td>6.45%</td>
<td>-4.96%</td>
<td>2.54%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2023/1697727617_0.png" alt="eps graph" />
<h3>Stock Performance</h3>
Shares of World Acceptance were trading at $120.45 as of October 18. Over the last 52-week period, shares are up 15.86%. Given that these returns are generally positive, long-term shareholders should be satisfied going into this earnings release. 
<a href="https://www.benzinga.com/quote/WRLD/earnings">To track all earnings releases for World Acceptance visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

A Preview Of World Acceptance's Earnings

The U.S. Supreme Court is scheduled to hear a case on Tuesday concerning the funding structure of the Consumer Financial Protection Bureau (CFPB), the agency created following the 2008 financial crisis to protect consumers from predatory lending and <a href="https://www.benzinga.com/topic/cfpb">other deceptive practices</a>.
Central to the case, named CFPB v. Community Financial Services Association of America, is the constitutionality of the CFPB&#8217;s funding. Currently, the CFPB draws its annual funding from the Federal Reserve rather than from budgets approved by Congress. A lower court — the 5th U.S. Circuit Court of Appeals — ruled in October of last year that the CFPB's funding mechanism violates the Constitution's appropriations clause, which bestows Congress with the power of the purse.
Payday lenders, represented by trade groups, started the challenge against the CFPB, according to a Reuters report. They targeted a 2017 CFPB rule that prohibited lenders from charging a borrower&#8217;s bank account after two consecutive failed attempts due to insufficient funds. Read also: <a href="https://www.benzinga.com/23/10/35065240/us-job-openings-surge-by-690-000-in-august-defy-expectations">US Job Openings Surge By 690,000 In August, Defy Expectations</a>
If the Supreme Court sides with the trade group here, the implications for consumers are palpable.
Any regulations the CFPB has issued over the past 12 years — covering areas like credit cards, mortgages, and debt collection — could be nullified. More to that, the funding model of other regulators, like the Federal Reserve, and programs like Social Security could come under scrutiny.
A judgment in the case could be rendered by June of next year.
While the case is in its early stages, investors should keep an eye out for stocks exposed to the payday loan sector, including: Firstcash Holdings Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FCFS#NASDAQ">FCFS</a>), Oppfi Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OPFI#NYSE">OPFI</a>), World Acceptance Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WRLD#NASDAQ">WRLD</a>), and EZCORP Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EZPW#NASDAQ">EZPW</a>).
ETFs like First Trust Multi-Manager Sm Cap Opportunities ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMSC#NYSE">MMSC</a>), Invesco S&amp;P SmallCap 600 Pure Value ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RZV#NYSE">RZV</a>), and Invesco Dorsey Wright Financial Momentum ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PFI#NASDAQ">PFI</a>) that have exposure to payday loans may be impacted. Read next: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/23/10/35062922/higher-rates-lower-leverage-growth-stocks-to-struggle-while-ai-offers-hope-goldman-">Higher Rates, Lower Leverage: Growth Stocks To Struggle While AI Offers Hope, Goldman Sachs Analysts Say</a>
Photo: Shutterstock

Equities

Government

Mid Cap

Regulations

Sector ETFs

Specialty ETFs

Topics

ETFs

General

EZPW

FCFS

MMSC

OPFI

PowerShares Dynamic Financial Sector Portfolio

Rydex ETF Trust S&P Smallcap 600 Pure Value ETF

Payday Lenders Challenge Financial Consumer Watchdog's Budget Structure In Supreme Court: What It Means For Your Wallet

BMO Capital Markets&nbsp;analyst James Fotheringham reiterated an Underperform rating on&nbsp;World Acceptance Corporation&nbsp;(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wrld#NASDAQ">WRLD</a>),&nbsp;<a class="editor-rtfLink" href="https://www.benzinga.com/quote/wrld/analyst-ratings" style="background-image:initial; background-position:initial; background-size:initial; background-repeat:initial; background-attachment:initial; background-origin:initial; background-clip:initial; margin-top:0pt; margin-bottom:0pt; color:#4a6ee0" target="_blank">raising the price target to $59 from $47</a>.
WRLD reported its&nbsp;<a class="editor-rtfLink" href="https://www.benzinga.com/news/earnings/23/07/33322434/why-world-acceptance-shares-are-gaining-today" style="background-image:initial; background-position:initial; background-size:initial; background-repeat:initial; background-attachment:initial; background-origin:initial; background-clip:initial; margin-top:0pt; margin-bottom:0pt; color:#4a6ee0" target="_blank">first quarter revenues of $139.32 million</a>, down 11.8% year over year. Revenues beat the consensus of $135.81 million. EPS of $1.62&nbsp;<a class="editor-rtfLink" href="https://www.benzinga.com/calendars/earnings" style="background-image:initial; background-position:initial; background-size:initial; background-repeat:initial; background-attachment:initial; background-origin:initial; background-clip:initial; margin-top:0pt; margin-bottom:0pt; color:#4a6ee0" target="_blank">beat the consensus of $0.63</a>.&nbsp;
The analyst notes that WRLD reported<a class="editor-rtfLink" href="https://www.benzinga.com/calendars/earnings" style="background-image:initial; background-position:initial; background-size:initial; background-repeat:initial; background-attachment:initial; background-origin:initial; background-clip:initial; margin-top:0pt; margin-bottom:0pt; color:#4a6ee0" target="_blank">&nbsp;improving credit, rising yields, and fast growth in new loan originations</a>; however, the analyst predicts these trends not to sustain.
The analyst adds that interest and insurance yields increased +140 bps QoQ and +130 bps YoY due to shifting the portfolio mix towards smaller loans.
WRLD&#39;s small loan portfolio grew in FY1Q24 while its large loan book declined in absolute terms.
Fotheringham assumes the company&#39;s credit costs to rise as it consciously increases approval rates to new customers and shifts the portfolio to smaller loans.
WRLD&#39;s quarterly NCO rate averaged 23.6% over the past four quarters (high by historical standards) but fell to 16.9% in FY1Q24.&nbsp;
The analyst forecasts NCO rates in the high teens for the foreseeable future.&nbsp;
The analyst&nbsp;<a class="editor-rtfLink" href="https://www.benzinga.com/calendars/guidance" style="background-image:initial; background-position:initial; background-size:initial; background-repeat:initial; background-attachment:initial; background-origin:initial; background-clip:initial; margin-top:0pt; margin-bottom:0pt; color:#4a6ee0" target="_blank">raised WRLD core EPS estimates by +15% in FY2024</a>E (to $6.69 from $5.81) and +20% in FY2025E (to $7.90 from $6.57) due to higher than previously modeled revenues and lower expected credit provisions.
Price Action:&nbsp;WRLD shares are trading higher by 0.05% to $150.94&nbsp;on the last check Monday.

Analyst Color

Reiteration

World Acceptance To Gain From Lower Credit Provisions In FY24, Analyst Raises Estimates

BMO Capital analyst James Fotheringham maintains World Acceptance (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WRLD#NASDAQ">WRLD</a>) with a Underperform and raises the price target from $47 to $59.

BMO Capital Maintains Underperform on World Acceptance, Raises Price Target to $59